Stimulus-induced focal motor seizure in a pediatric patient with carbamazepine overdose

Brain Dev. 2022 Nov;44(10):765-768. doi: 10.1016/j.braindev.2022.06.007. Epub 2022 Jul 6.

Abstract

Introduction: Carbamazepine (CBZ) is a common antiepileptic drug that may cause overdoses with seizures as a common neurological manifestation. In previous reports, patients with CBZ overdose exhibited stimulus-induced generalized clinical or electrical seizures. To date, no previous cases of focal motor seizures have been reported.

Case report: We report the case of an 11-year-old girl with spontaneous and stimulus-induced clustering of focal motor seizures following CBZ overdose. The patient had been treated with CBZ (150 mg daily) for focal epilepsy since the age of six years. At the age of 11, she forgot to take a morning dose, took ten CBZ pills (CBZ 1000 mg) as compensation, and presented with generalized seizures. The patient arrived at the hospital in a coma. She demonstrated clustering of focal-to-bilateral tonic-clonic seizures induced by pain stimulus or spontaneously, with focal epileptiform discharges observed on EEG. Her CBZ blood concentration measured 40.4 μg/mL and she was diagnosed with CBZ overdose. The patient showed improvement without any specific treatment, and was later discharged without neurological sequelae.

Conclusion: Previous cases of CBZ overdose with stimulus-induced generalized seizures resulted in death or required intensive care. Stimulus-induced focal seizures may indicate a favorable prognosis for CBZ overdose.

Keywords: Carbamazepine; Focal onset seizure; Overdose; Stimulus-induced seizure.

Publication types

  • Case Reports

MeSH terms

  • Anticonvulsants / therapeutic use
  • Benzodiazepines / therapeutic use
  • Carbamazepine / therapeutic use
  • Child
  • Drug Overdose* / complications
  • Epilepsies, Partial* / drug therapy
  • Female
  • Humans
  • Seizures / chemically induced
  • Seizures / drug therapy

Substances

  • Carbamazepine
  • Anticonvulsants
  • Benzodiazepines